MannKind Corporation Dividend History (MNKD)

About MannKind Corporation

MannKind Corporation is a biopharmaceutical company that was founded in February 1991 by Alfred E. Mann. Headquartered in Westlake Village, California, the company specializes in the development and commercialization of inhalable therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is best known for its lead product, Afrezza, an inhalable insulin for adults with diabetes, which offers a rapid-acting alternative to injectable insulin. The company is driven by a commitment to improve the lives of patients through innovative medical solutions. MannKind's focus on patient-centric therapies and advanced drug delivery technologies positions it uniquely within the biotech industry, with a mission to enhance convenience and quality of life for those living with chronic conditions. As of recent financial disclosures, MannKind's revenue continues to grow, reflecting its expanding market presence and strategic partnerships.